Your browser doesn't support javascript.
loading
Diagnosis of "cribriform" prostatic adenocarcinoma: an interobserver reproducibility study among urologic pathologists with recommendations.
Shah, Rajal B; Cai, Qi; Aron, Manju; Berney, Daniel M; Cheville, John C; Deng, Fang-Ming; Epstein, Jonathan; Fine, Samson W; Genega, Elizabeth M; Hirsch, Michelle S; Humphrey, Peter A; Gordetsky, Jennifer; Kristiansen, Glen; Kunju, Lakshmi P; Magi-Galluzzi, Cristina; Gupta, Nilesh; Netto, George J; Osunkoya, Adeboye O; Robinson, Brian D; Trpkov, Kiril; True, Lawrence D; Troncoso, Patricia; Varma, Murali; Wheeler, Thomas; Williamson, Sean R; Wu, Angela; Zhou, Ming.
Afiliação
  • Shah RB; Department of Pathology, The University of Texas Southwestern Medical Center Dallas, TX, USA.
  • Cai Q; Department of Pathology, The University of Texas Southwestern Medical Center Dallas, TX, USA.
  • Aron M; Department of Pathology, University of Southern California Los Angeles, CA, USA.
  • Berney DM; Department of Cellular Pathology, Bartshealth NHS Trust and Barts Cancer Institute, Queen Mary University of London United Kingdom.
  • Cheville JC; Department of Laboratory Medicine and Pathology, Mayo Clinic Rochester, MN, USA.
  • Deng FM; Department of Pathology, New York University Medical Center New York, NY, USA.
  • Epstein J; Department of Pathology, Urology, Oncology, The Johns Hopkins Medical Institutions Baltimore, MD, USA.
  • Fine SW; Department of Pathology, Memorial Sloan Kettering Cancer Center New York, NY, USA.
  • Genega EM; Department of Pathology, Tufts Medical Center Boston, MA, USA.
  • Hirsch MS; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School Boston, MA, USA.
  • Humphrey PA; Department of Pathology, Yale School of Medicine New Haven, CT, USA.
  • Gordetsky J; Department of Pathology, Microbiology and Immunology, Urology, Vanderbilt University Medical Center Nashville, TN, USA.
  • Kristiansen G; Institute of Pathology of The University Hospital Bonn Bonn, Germany.
  • Kunju LP; Department of Pathology at Michigan Medicine, University of Michigan Medical School Ann Arbor, MI, USA.
  • Magi-Galluzzi C; Department of Pathology, University of Alabama at Birmingham Birmingham, AL, USA.
  • Gupta N; Department of Pathology, Henry Ford Health System Detroit, MI, USA.
  • Netto GJ; Department of Pathology, University of Alabama at Birmingham Birmingham, AL, USA.
  • Osunkoya AO; Department of Pathology and Urology, Emory University School of Medicine Atlanta, GA, USA.
  • Robinson BD; Department of Pathology, Weill Cornell Medicine New York, NY, USA.
  • Trpkov K; Department of Pathology and Laboratory Medicine, Cumming School of Medicine, University of Calgary Calgary, AB, Canada.
  • True LD; Department of Laboratory Medicine and Pathology, University of Washington School of Medicine Seattle, Washington, USA.
  • Troncoso P; Department of Pathology, The University of Texas MD Anderson Cancer Center Houston, TX, USA.
  • Varma M; Department of Cellular Pathology, University Hospital of Wales Cardiff, Wales, United Kingdom.
  • Wheeler T; Department of Pathology & Immunology, Baylor College of Medicine Houston, TX, USA.
  • Williamson SR; Robert J. Tomsich Pathology and Laboratory Medicine Institute, Cleveland Clinic Cleveland, OH, USA.
  • Wu A; Department of Pathology at Michigan Medicine, University of Michigan Medical School Ann Arbor, MI, USA.
  • Zhou M; Department of Pathology, Tufts Medical Center Boston, MA, USA.
Am J Cancer Res ; 11(8): 3990-4001, 2021.
Article em En | MEDLINE | ID: mdl-34522463
ABSTRACT
Accurate diagnosis of cribriform Gleason pattern 4 (CrP4) prostate adenocarcinoma (PCa) is important due to its independent association with adverse clinical outcomes and as a growing body of evidence suggests that it impacts clinical decision making in PCa management. To identify reproducible features for diagnosis of CrP4, we assessed interobserver agreement among 27 experienced urologic pathologists of 60 digital images from 44 radical prostatectomies (RP) that represented a broad spectrum of potential CrP4. The following morphologic features were correlated with the consensus diagnosis (defined as 75% agreement) for each image partial vs. transluminal glandular bridging, intraglandular stroma, <12 vs. ≥12 lumina, well vs. poorly formed lumina, mucin (mucinous fibroplasia, extravasation, or extracellular pool), size (compared to benign glands and number of lumina), number of attachments with gland border by tumor cells forming a "glomeruloid-like" pattern, a clear luminal space along the periphery of gland occupying <50% of glandular circumference, central nerve, dense (cell mass occupying >50% of luminal space) vs. loose, and regular vs. irregular contour. Interobserver reproducibility for the overall diagnostic agreement was fair (k=0.40). Large CrP4 had better agreement (k=0.49) compared to small CrP4 (k=0.40). Transluminal bridging, dense cellular proliferation, a clear luminal space along the periphery of gland occupying <50% of gland circumference, lack of intraglandular mucin, and lack of contact between the majority of intraglandular cells with stroma were significantly associated with consensus for CrP4. In contrast, partial bridging, majority of intraglandular cells in contact with stroma, mucinous fibroplasia, only one attachment to the gland border by tumor cells forming a "glomeruloid-like" pattern, and a clear luminal space along the periphery of gland accounting for >50% of the glandular circumference were associated with consensus against CrP4. In summary, we identified reproducible morphological features for and against CrP4 diagnosis, which could be used to refine and standardize the diagnostic criteria for CrP4.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Guideline / Prognostic_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Guideline / Prognostic_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article